092040.KQ
Amicogen, Inc.
KOE · Healthcare · Biotechnology · KR
KRW 986.00
+2.18%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 0.47x
- Price / sales
- 1.18x
- Price / cash flow
- -90.63x
Enterprise value
- Enterprise value
- KRW 105.0B
- EV / sales
- 2.25x
- EV / EBITDA
- -11.67x
- EV / EBIT
- -8.24x
- Market cap
- KRW 54.9B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026